Clinical TrialsSearch results
Number of results: 216
Other
- Clinical study for the first relapsed ALL in children. JPLSG ALL-R08-II: Multicenter phase II clinical trial for children with non-T-ALL in intermediate risk group stratified by the minimal residual disease (MRD).
- first relapsed acute lymphoblastic leukemia in children
- Japanese Peditric Leukemia/Lymphoma Study Group(JPLSG)
- 2009-06-01
Recruiting
- Effectiveness of PEG-IFN alfa-2b + Ribavirin combination therapy in patients with chronic hepatitis C after partial splenic embolization(PSE) or splenectomy
- Chronic Hepatitis C
- Tokushima Municipal Hospital
- 2009-06-01
Other
- Biomarker-Cohort Study of Adjuvant Chemotherapy for Stage III Colon Cancer
- Colon cancer
- Tokyo Medical and Dental University
- 2009-05-29
Other
- Multi-Center Phase II Study on Efficacy of High-Slip Skin Care Pad for Hand-Foot Skin Reaction Caused by Sorafenib in Patients with Renal Cell Carcinoma
- Renal cell carcinoma
- Japanese Society of Renal Cancer (JSRC)
- 2009-05-29
Other
- Prospective Study of hyperphosphatemia in CKD5D patients undergoing hemodialysis (STOP-HD).
- Hemodialysis patients with hyperphosphatemia
- Phosphate Research group
- 2009-05-25
Other
- Randomized multi-institutional study for effectiveness of intervention on life style in obese patients with fasting hyperglycemia or abnormal glucose tolerance test.
- Diabetes mellitus (Pre-diabetes )
- All Japan Federation of Social Insurance Associations
- 2009-05-12
Other
- Multicenter registry study with therapeutic hypothermia after cardiac arrest in Japan
- Cardiac Arrest
- National Cardiovascular Center
- 2009-05-02
Other
- A multicenter observational study of clinical relevance of microalbuminuria and intra-renal RAS in type 2 diabetes.
- Type 2 Diabetes Mellitus
- Kagawa University, Faculty of Medicine
- 2009-04-14
Other
- A prospective, time-series, multicenter study on the effect of telmisartan on intra-renal RAS in type 2 diabetes.
- Type 2 Diabetes Mellitus
- Kagawa University, Faculty of Medicine
- 2009-04-14
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Metformin
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2009-04-01